Peripheral arterial disease (PAD) affects a large number of individuals over 55 years old, and data from studies has shown a relationship between inflammation and PAD. Many researches have not only focused on the role played by inflammatory biomarkers and the progression of PAD, but also on the efficiency of biomarkers in monitoring medical, surgical and interventional strategies in PAD patients. In this review, Authors ain to demonstrate the biomarkers play a key role iin the pathophisiology of PAD,a nd consequently they could be screen to highlight individual showing these crucial pathpphysiological signs. Based on a large debate abiut phlogosis, it is now considered to be a relevant objective in reducing the prevalence and consequences of atherosclerotic diseases such as PAD. Finally, efforts must be to made towards addressing this very important objective, and consequently a greater number of studied need in combating phlogosis, especially among PAD patients.
|Titolo:||Inflammation in peripheral arterial disease (PAD).|
|Data di pubblicazione:||2012|
|Citazione:||Inflammation in peripheral arterial disease (PAD). / Signorelli S. - In: CURRENT PHARMACEUTICAL DESIGN. - ISSN 1381-6128. - 18:28(2012), pp. 4350-4357.|
|Appare nelle tipologie:||1.1 Articolo in rivista|